ENTITY
Dechra Pharmaceuticals

Dechra Pharmaceuticals (DPH LN)

44
Analysis
Health Care • United Kingdom
Dechra Pharmaceuticals is a global specialist in the development, manufacture, and marketing of high-quality veterinary pharmaceuticals and related products, focusing on companion animals, equine, and food-producing animals. Key products include treatments for endocrinology, dermatology, and pain management, such as Vetoryl for Cushing's disease in dogs and Felimazole for hyperthyroidism in cats. The company was founded in 1997 and moved its global headquarters to Boston, Massachusetts, in June 2026.
more
•22 Oct 2023 07:05

Last Week In Event SPACE: Shinko Electric Industries, MGM China, Decente, Sankei Real Estate,

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
825 Views
Share
bullish•NEL ASA
•19 Oct 2023 18:03

Quiddity Leaderboard SE600 Dec 23: Novartis-Sandoz, Dechra, CHR, and Others

I currently see six regular ADDs/DELs for the SE600 index in December 2023. Apart from that the Dechra and CHR deals could trigger two more intra...

Share
bearish•Evoke
•17 Oct 2023 17:32

Quiddity Leaderboard F100/​​​250 Dec 23: ~7 Changes Possible; LONG Playtech SHORT 888 Interesting

The top 7 F250 Potential ADDs currently have ~10 days of volume to buy and up to a couple of these names could be added on an intra-review basis...

Share
bullish•Synthomer
•26 Sep 2023 18:50

Quiddity Leaderboard SE600 Dec 23: 7 Changes Possible Including Two Intra-Review Changes

If the Dechra Pharma and Chr Hansen deals close prior to the Dec 23 review, there will be intra-review replacements. Synthomer and Adevinta are...

Share
bullish•Hunting
•21 Sep 2023 22:50

Quiddity Leaderboard F100/​​​250 Dec 23: Dechra, Network International, and Other Potential Changes

Tullow Oil, Kier Group, and AO world are currently the top 3 F250 potential ADDs. Alfa Financial, ASOS, and XP power are next in line. There could...

Share
x